does mounjaro have glp-1 in it for Weight Loss What are GLP-1 medications and

Overall, the findings provide cautious, low-certainty reassurance regarding inadvertent maternal exposure, particularly during early pregnancy, but do not establish that these drugs are safe for routine use throughout pregnancy

In the same trial, people on CagriSema lost an average of about 23% of their body weight over 68 weeks when measuring the effect assuming full adherence, or about 21% when accounting for all participants regardless of whether they completed treatment

Aug 2023;42(8):1314-1321

Sales of its GLP-1s Mounjaro and Zepbound bumped Q3 2025 revenue 54% YoY to $17.6 billion, the company shared on Oct

This shifts the narrative from "weight loss" to "medical necessity." Submit Your Appeal You typically have 180 days (six months) from the denial date to file an appeal